Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis. (2021). SKIN The Journal of Cutaneous Medicine, 5(1), s9. https://doi.org/10.25251/skin.5.supp.9